Cargando…

Oncolytic adenovirus-mediated mda-7/IL-24 expression suppresses osteosarcoma growth and enhances sensitivity to doxorubicin

Detalles Bibliográficos
Autores principales:	Liu, Zongming, Xu, Libo, Yuan, Hongping, Zhang, Yang, Zhang, Xiaona, Zhao, Dongxu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503735/ https://www.ncbi.nlm.nih.gov/pubmed/34608497 http://dx.doi.org/10.3892/mmr.2021.12476

Ejemplares similares

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a
por: Zhou, Hui, et al.
Publicado: (2021)

Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin
por: Graat, H C A, et al.
Publicado: (2006)

A novel oncolytic adenovirus based on simian adenovirus serotype 24
por: Cheng, Tao, et al.
Publicado: (2017)

Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2012)

Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway [Retraction]
Publicado: (2021)

Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
por: Wang, Cong-Jun, et al.
Publicado: (2012)

[Retracted] Ursolic acid suppresses the biological function of osteosarcoma cells
por: Pei, Yi, et al.
Publicado: (2023)

Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
por: Garcia-Moure, Marc, et al.
Publicado: (2016)

Retracted: Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retraction: SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion
Publicado: (2023)

Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction]
Publicado: (2022)

Retraction Notice to: Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression
por: Qi, Xu, et al.
Publicado: (2022)

MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo
por: Gopalan, Began, et al.
Publicado: (2007)

Retraction: Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation
Publicado: (2023)

Synergistic Suppression Effect on Tumor Growth of Acute Myeloid Leukemia by Combining Cytarabine with an Engineered Oncolytic Vaccinia Virus [Retraction]
Publicado: (2022)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2023)

Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer
por: Mao, Li-jun, et al.
Publicado: (2018)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
por: Modi, Jinkal, et al.
Publicado: (2021)

Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
por: Liu, Zhen, et al.
Publicado: (2019)

Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN [Retraction]
Publicado: (2023)

Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
por: Zhang, Song-Nan, et al.
Publicado: (2011)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)

Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021)

A Renaissance for Oncolytic Adenoviruses?
por: Blanchette, Paola, et al.
Publicado: (2023)

MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver
por: Ylösmäki, Erkko, et al.
Publicado: (2013)

MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
por: Sun, Yangbai, et al.
Publicado: (2016)

Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
Publicado: (2019)

MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling
por: Zhang, Can, et al.
Publicado: (2021)

Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation
por: Mao, Li-jun, et al.
Publicado: (2020)

MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS
por: Wang, Zili, et al.
Publicado: (2021)

Retraction: MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma
Publicado: (2022)

Retraction: MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells
Publicado: (2022)

miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1
por: Li, Chang-Hui, et al.
Publicado: (2022)

Retraction: MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7
Publicado: (2023)

[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway
por: Liu, Jiaguo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vn4fo35hv28j3f5nibp15shqfa